Ankle-brachial index in patients with diabetes mellitus: Prevalence and risk factors;Índice tobillo-brazo en pacientes con diabetes mellitus: Prevalencia y factores de riesgo

Revista Clinica Espanola

Volumn 206, Issue 5, 2006, Pages 225-229

  Vicente, I ^a   Lahoz, C ^b   Taboada, M ^a   Laguna, F ^b   Garcia Iglesias F ^b   Mostaza Prieto, J M ^b  

^a Centro de Salud Fuencarral   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Ankle brachial index; Cardiovascular disease; Peripheral artery disease; Type 2 diabetes mellitus

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT; BIOLOGICAL MARKER;

ADULT; AGE; AGED; ANKLE BRACHIAL INDEX; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIET THERAPY; DISEASE DURATION; FEMALE; GENDER; HUMAN; INFORMED CONSENT; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PERIPHERAL VASCULAR DISEASE; PREVALENCE; PRIMARY MEDICAL CARE; RISK FACTOR; ANKLE; BRACHIAL ARTERY; DIABETES MELLITUS; DOPPLER ECHOGRAPHY; ECHOGRAPHY; HYPERCHOLESTEROLEMIA; HYPERTENSION; PATHOPHYSIOLOGY;

AGED; ANKLE; BIOLOGICAL MARKERS; BRACHIAL ARTERY; DIABETES MELLITUS; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; PREVALENCE; RISK FACTORS; ULTRASONOGRAPHY, DOPPLER, DUPLEX;

EID: 33745698565     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: 10.1157/13088561     Document Type: Article

References (17)

1. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care. 1993;16(2):434-44.
2. Miettinen H, Lehto S, Salomaa V, Mahonen M, Niemela M, Haffner SM, et al. Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA myocardial infarction register study group. Diabetes Care. 1998;21(1):69-75.
3. Herlitz J, Karlson BW, Lindqvist J, Sjolin M. Rate and mode of death during five years of follow-up among patients with acute chest pain with and without a history of diabetes mellitus. Diabet Med. 1998;15(4):308-14.
4. Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ, et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care. 2004;27(8):1954-61.
5. Mostaza JM, Vicente I, Cairols M, Castillo J, González-Juanatey JR, Pomar JL, et al. Indice tobillo-brazo y riesgo cardiovascular. Med Clin (Barc). 2003;121(2):68-73.
6. Consensus development conference on the diagnosis of coronary heart disease in people with diabetes: 10-11 February 1998, Miami, Florida. American Diabetes Association. Diabetes Care. 1998;21(9):1551-9.
7. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-97.
8. Resnick HE, Lindsay RS, McDermott MM, Devereux RB, Jones KL, Fabsitz RR, et al. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Circulation. 2004;109(6):733-9.
9. Ogren M, Hedblad B, Engstrom G, Janzon L. Prevalence and prognostic significance of asymptomatic peripheral arterial disease in 68-year-old men with diabetes. Results from the population study «Men born in 1914» from Malmo, Sweden. Eur J Vasc Endovasc Surg. 2005; 29(2):182-9.
10. Kallio M, Forsblom C, Groop PH, Groop L, Lepantalo M. Development of new peripheral arterial occlusive disease in patients with type 2 diabetes during a mean follow-up of 11 years. Diabetes Care. 2003; 26(4):1241-5.
11. Murabito JM, Evans JC, Nieto K, Larson MG, Levy D, Wilson PW. Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J. 2002;143(6):961-5.
12. Curb JD, Masaki K, Rodríguez BL, Abbott RD, Burchfiel CM, Chen R, et al. Peripheral artery disease and cardiovascular risk factors in the elderly. The Honolulu Heart Program. Arterioscler Thromb Vasc Biol. 1996; 16(12):1495-500.
13. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004;110(10):1245-50.
14. Rajagopalan N, Miller TD, Hodge DO, Frye RL, Gibbons RJ. Identifying high-risk asymptomatic diabetic patients who are candidates for screening stress single-photon emission computed tomography imaging. J Am Coll Cardiol. 2005;45(1):43-9.
15. Di Carli MF, Hachamovitch R. Should we screen for occult coronary artery disease among asymptomatic patients with diabetes? J Am Coll Cardiol. 2005;45(1):50-3.
16. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998; 339(4):229-234.
17. Evans JM, Wang J, Morris AD. Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies. BMJ. 2002; 324(7343):939-42.